Among people with type 2 diabetes, GLP-1 receptor agonist users show a lower incidence of Parkinson's disease (Brauer et al., 2020
It is because the estrogen and progesterone production of the body fluctuate so often, which leads to undesired changes in the body and mood
Online products labeled for research purposes only operate entirely outside regulatory oversight, making their safety and dosing highly uncertain
That fundamental research research like the kind Richard DiMarchi conducts has to come from laboratories at universities, smaller companies and startups. When the chemistry department recruited DiMarchi, he insisted his lab be in Bloomington, even though it initially required travel from his primary residence in Carmel, Indiana, because at the core I am a chemist, and the chemistry department at Indiana University Bloomington is world-class. Clemmer, who was chair of the department when DiMarchi joined, said he was able to recruit DiMarchi because of the opportunity to collaborate with the departments visionary researchers and access other leading academic researchers like German physician Matthias Tschp, a key player in the refinement of GLP-1 drugs for obesity treatment
Images were analysed as previously described (82, 83)
plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports, Reuters (2025) Medicare coverage of GLP-1 drugs, Library of Congress (2024) WEGOVY- semaglutide injection, solution, DailyMed (2024) Supriya Rao, MD, gastroenterologist, director of medical weight loss at Lowell General Hospital, and clinical assistant professor at Tufts University School of Medicine Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
